USP17 interacted with and disrupted the TRAF2/TRAF3 complex through reducing K63-linked ubiquitination of TRAF2 and TRAF6. This activity positively drives stemness and inflammation in lung cancer (Lu et al., 2018). Here, TRAF2 is linked to lung carcinoma.